Jean-François Fonteneau Selected Research

Jean-François Fonteneau Research Topics

Disease

31	Neoplasms (Cancer) 04/2024 - 09/2005
9	Melanoma (Melanoma, Malignant) 10/2023 - 09/2007
8	Mesothelioma 12/2022 - 12/2015
7	Malignant Mesothelioma 01/2020 - 03/2012
5	Infections 10/2023 - 05/2003
2	Testicular Neoplasms (Testicular Cancer) 10/2023 - 03/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024
1	Lung Neoplasms (Lung Cancer) 04/2024
1	Measles 10/2023
1	Hypersensitivity (Allergy) 07/2017
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2017
1	Pleural Effusion (Pleural Effusions) 10/2016
1	Adenocarcinoma of Lung 06/2014
1	Colorectal Neoplasms (Colorectal Cancer) 01/2013
1	Hodgkin Disease (Hodgkin's Disease) 09/2005
1	Nasopharyngeal Carcinoma 09/2005

Drug/Important Bio-Agent (IBA)

8	AntigensIBA 10/2023 - 09/2005
6	Interferon Type IIBA 12/2022 - 12/2015
6	VaccinesIBA 06/2013 - 10/2007
5	Proteins (Proteins, Gene)FDA Link 04/2024 - 02/2014
5	Peptides (Polypeptides)IBA 10/2023 - 09/2007
5	Neoplasm Antigens (Tumor Antigens)IBA 10/2023 - 01/2013
4	AsbestosIBA 12/2022 - 10/2016
4	EpitopesIBA 06/2013 - 09/2007
3	ruxolitinibIBA 12/2022 - 01/2017
3	MART-1 AntigenIBA 05/2008 - 09/2007
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2020
2	InterferonsIBA 01/2021 - 01/2017
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 01/2017
2	CytokinesIBA 01/2020 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 06/2014
2	ChemokinesIBA 10/2016 - 05/2003
2	Differentiation AntigensIBA 05/2008 - 10/2007
1	3' Untranslated Regions (3' UTR)IBA 12/2022
1	Adenosine DeaminaseIBA 12/2022
1	Nucleic AcidsIBA 12/2022
1	Diuron (DCMU)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2021
1	Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link 12/2020
1	Poly I-CIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Toll-Like Receptor 3IBA 01/2020
1	Macrophage Colony-Stimulating FactorIBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Granzymes (Granzyme)IBA 01/2020
1	Death Domain ReceptorsIBA 01/2020
1	HLA-DPw4 antigenIBA 01/2018
1	Attenuated VaccinesIBA 01/2017
1	Pattern Recognition ReceptorsIBA 01/2017
1	LigandsIBA 10/2016
1	Monoclonal AntibodiesIBA 03/2015
1	Messenger RNA (mRNA)IBA 06/2014
1	Histone Deacetylase InhibitorsIBA 06/2014
1	Vorinostat FDA Link 06/2014
1	HLA-A3 Antigen (HLA A3 Antigen)IBA 02/2014
1	Complement System Proteins (Complement)IBA 03/2013
1	Antineoplastic Agents (Antineoplastics)IBA 03/2013
1	Caspase 3 (Caspase-3)IBA 01/2013
1	Glycoproteins (Glycoprotein)IBA 01/2013
1	HLA-DQ5 antigenIBA 10/2007
1	Cancer VaccinesIBA 09/2007

Therapy/Procedure

8	Therapeutics 04/2024 - 03/2012
8	Immunotherapy 09/2020 - 10/2007
3	Drug Therapy (Chemotherapy) 04/2024 - 01/2020
1	Transplantation 06/2016
1	Oncolytic Virotherapy 01/2015